Have a feature idea you'd love to see implemented?
Let us know!
GMED Globus Medical Inc
Price (delayed)
$75.15
Market cap
$10.18B
P/E Ratio
300.6
Dividend/share
N/A
EPS
$0.25
Enterprise value
$10.29B
Based in Audubon, Pennsylvania, Globus Medical, Inc. was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing
Highlights
Globus Medical's revenue has surged by 104% YoY and by 18% QoQ
GMED's equity has surged by 100% year-on-year
GMED's quick ratio has dropped by 75% year-on-year but it is up by 13% since the previous quarter
The P/E is 167% more than the last 4 quarters average of 111.3
The EPS has dropped by 88% year-on-year and by 58% since the previous quarter
Key stats
What are the main financial stats of GMED
Market
Valuations
Earnings
Shares outstanding
135.41M
Market cap
$10.18B
Enterprise value
$10.29B
Price to earnings (P/E)
300.6
Price to book (P/B)
2.55
Price to sales (P/S)
4.54
EV/EBIT
157.31
EV/EBITDA
35.15
EV/Sales
4.6
Revenue
$2.24B
EBIT
$65.44M
EBITDA
$292.84M
Free cash flow
$161.02M
Per share
Balance sheet
Liquidity
EPS
$0.25
Free cash flow per share
$1.19
Book value per share
$29.44
Revenue per share
$16.54
TBVPS
$19.77
Total assets
$4.99B
Total liabilities
$1.02B
Debt
$529.31M
Equity
$3.98B
Working capital
$1.13B
Debt to equity
0.13
Current ratio
2.42
Quick ratio
1.39
Net debt/EBITDA
0.41
Margins
Efficiency
Dividend
EBITDA margin
13.1%
Gross margin
59.7%
Net margin
1.8%
Operating margin
3%
Return on assets
0.8%
Return on equity
1%
Return on invested capital
2.9%
Return on capital employed
1.6%
Return on sales
2.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GMED stock price
How has the Globus Medical stock price performed over time
Intraday
1.16%
1 week
1.71%
1 month
5.05%
1 year
64.87%
YTD
41.02%
QTD
5.05%
Financial performance
How have Globus Medical's revenue and profit performed over time
Revenue
$2.24B
Gross profit
$1.33B
Operating income
$68.15M
Net income
$40.68M
Gross margin
59.7%
Net margin
1.8%
Globus Medical's revenue has surged by 104% YoY and by 18% QoQ
The net margin has dropped by 90% year-on-year and by 49% since the previous quarter
The company's operating margin has shrunk by 86% YoY and by 33% QoQ
The company's net income has shrunk by 80% YoY and by 39% QoQ
Growth
What is Globus Medical's growth rate over time
Valuation
What is Globus Medical stock price valuation
P/E
300.6
P/B
2.55
P/S
4.54
EV/EBIT
157.31
EV/EBITDA
35.15
EV/Sales
4.6
The P/E is 167% more than the last 4 quarters average of 111.3
The EPS has dropped by 88% year-on-year and by 58% since the previous quarter
GMED's equity has surged by 100% year-on-year
The stock's P/B is 40% more than its last 4 quarters average of 1.8 but 26% less than its 5-year quarterly average of 3.4
Globus Medical's revenue has surged by 104% YoY and by 18% QoQ
GMED's P/S is 29% lower than its 5-year quarterly average of 6.3 but 10% higher than its last 4 quarters average of 4.1
Efficiency
How efficient is Globus Medical business performance
The ROA has dropped by 92% year-on-year and by 47% since the previous quarter
Globus Medical's return on equity has shrunk by 91% YoY and by 47% QoQ
The return on sales has dropped by 87% year-on-year and by 33% since the previous quarter
GMED's ROIC has dropped by 82% year-on-year and by 24% since the previous quarter
Dividends
What is GMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GMED.
Financial health
How did Globus Medical financials performed over time
GMED's total assets has surged by 126% year-on-year
GMED's quick ratio has dropped by 75% year-on-year but it is up by 13% since the previous quarter
The debt is 87% smaller than the equity
GMED's equity has surged by 100% year-on-year
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.